Pangenomic Health Inc.
NARA
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -144.90K | -1.86M | -162.30K | -406.40K | -298.50K |
| Total Depreciation and Amortization | 1.50K | 2.30K | 2.30K | 2.30K | 2.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 23.50K | 1.70M | 28.80K | -700.00 | 20.30K |
| Change in Net Operating Assets | 131.10K | 112.10K | 142.70K | 154.00K | 191.00K |
| Cash from Operations | 11.30K | -43.50K | 11.60K | -250.80K | -84.90K |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | 0.00 | 47.00K | -- | 338.00K | 126.40K |
| Total Debt Repaid | -- | -- | -- | 110.90K | 0.00 |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -107.70K | -900.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -1.70K | -- | -- | 900.00 |
| Cash from Financing | 0.00 | 33.10K | -- | 250.80K | 94.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.30K | -10.40K | 11.60K | 0.00 | 9.30K |